Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Pertussis

View all HPV Plague Tetanus
Anthrax Influenza Pneumococcal Typhoid
Chickenpox Japanese encephalitis Polio Yellow fever
Diphtheria Measles Rabies Zoster
Hib Meningococcal Rotavirus
Hepatitis A Mumps Rubella
Hepatitis B Pertussis Smallpox
 

Recommendations - Pertussis

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57 (04):1-47,51
HTML pt 1  | HTML pt 2  | HTML pt 3  | PDF
 
Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 15, 2006;55(RR-17):1-33
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
Please note: If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
Source: MMWR, March 24, 2006, Vol. 55(RR03):1-49
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  HTML pt.5 |  HTML pt.6  |  HTML pt.7  |  PDF (entire issue)
 
CDC Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis
(not an ACIP statement but a recommendation from NIP, CDC)
Source: MMWR, December 9, 2005, Vol. 54(RR14):1-16
HTML  |  PDF
 
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13
HTML  |  PDF
 
Use of Acellular Pertussis Vaccines
Source: MMWR March 28, 1997 / Vol. 46 / No. RR-7
HTML  |  PDF
 
Diphtheria, Tetanus, and Pertussis, Recommendations for Vaccine Use and Other Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10
HTML  |  PDF
This page was reviewed on February 21, 2013
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.